The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say ...

Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

The intracranial stents market is experiencing rapid growth, fueled by the rising incidence of strokes, aneurysms, and ...

Boston Scientific Corporation develops ... such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters ...

Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

We recently published a list of Israel Englander’s Stock Portfolio: Top 10 Stocks to Invest in. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...

DelveInsight's Interventional Neuroradiology Market Insights report provides the current and forecast market analysis, individual leading interventional neuroradiology companies' market shares, ...

The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional ...